Goldman Sachs Starts Quintiles (Q) at Neutral
Tweet
Share
E-mailGet Alerts Q Hot Sheet
Price: $163.66 +1.53%
Rating Summary:
16 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 31
Rating Summary:
16 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 31
Join SI Premium – FREE
Goldman Sachs initiated coverage on Quintiles (NYSE: Q) with a Neutral rating and a price target of $44.00.
Analyst Robert P. Jones said, "We believe Quintiles' global scale and scientific expertise position the company well to take advantage of key Biopharma trends including (1) continued focus on advancing late-stage molecules; (2) deeper strategic outsourcing relationships; and (3) increasingly more complex pipelines. Additionally, we find Quintiles' stable financial profile attractive, especially relative to more volatile peers. That said, we believe valuation is appropriate with shares trading at 19.4X 2014 EPS, against our 2013E-2015E EPS CAGR of 16%."
For an analyst ratings summary and ratings history on Quintiles click here. For more ratings news on Quintiles click here.
Shares of Quintiles closed at $43.53 yesterday.
Analyst Robert P. Jones said, "We believe Quintiles' global scale and scientific expertise position the company well to take advantage of key Biopharma trends including (1) continued focus on advancing late-stage molecules; (2) deeper strategic outsourcing relationships; and (3) increasingly more complex pipelines. Additionally, we find Quintiles' stable financial profile attractive, especially relative to more volatile peers. That said, we believe valuation is appropriate with shares trading at 19.4X 2014 EPS, against our 2013E-2015E EPS CAGR of 16%."
For an analyst ratings summary and ratings history on Quintiles click here. For more ratings news on Quintiles click here.
Shares of Quintiles closed at $43.53 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Upgrades Telecom Argentina (TEO) to Overweight
- X-Energy Inc (XE) PT Lowered to $22 at Jefferies
- Cantor Fitzgerald Starts Silence Therapeutics (SLN) at Overweight
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS View, New CoverageRelated Entities
Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
